Olaparib in Patients With BRCA Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer
1 June 2013
Professor Jonathan Ledermann (UCL Cancer Institute) said: "These are encouraging results for patients with ovarian cancer who carry a BRCA听mutation. More: Wall Street Journal (no link)
Close
